It indicates that the DNA ploidy content play a role in the diagnosis, but there is no remarkable sense to tissuetyping, grading, PCNA express degree and prognosis of RMS.
You'd need to be closely matched by tissue-typing, but then it would only take a little immune-suppression medication to prevent rejection; we're getting better at that.